Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - (Details Narrative)

v3.20.2
Stock-Based Compensation - (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
May 01, 2020
Mar. 15, 2019
Jul. 31, 2020
May 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Jul. 24, 2020
Jul. 23, 2020
Proceeds from issuance of common stock               $ 5,480    
Contractual term                 1 year 6 months 3 days    
Expected stock price volatility                 53.00%    
Risk free interest rate                 1.80%    
Expected dividend rate                 0.00%    
Stock-based compensation expense         $ 529 $ 388 872   $ 847    
General and Administrative Expenses [Member]                      
Stock-based compensation expense         407 299 684   584    
Research and Development Expenses [Member]                      
Stock-based compensation expense         $ 122 89 $ 188   $ 263    
Employee Stock Purchase Plan [Member]                      
Vesting portion of stock             ESPP share purchase dates are March 31 and September 30. On the March 31, 2020 ESPP purchase date, 154 shares of PAVmed Inc. common stock were issued for proceeds of approximately $0.1 million.        
Number of common stock reserved         500   500        
Purchase price per share percentage on ESPP plan             85.00%        
Proceeds from issuance of common stock             $ 100        
Subsequent Event [Member] | Common Stock [Member] | Employee Stock Purchase Plan [Member]                      
Number of common stock reserved                   750 250
2014 Equity Plan [Member]                      
Aggregate Intrinsic Value         $ 2,468   2,468        
Aggregate Intrinsic Value, Vested and exercisable stock options         $ 1,263   $ 1,263        
Stock options granted             1,345        
Stock option granted, contractual term             10 years        
Stock option granted, weighted average exercise price             $ 2.18        
Vesting portion of stock             2014 Equity Plan, with each such stock option grant having a ten year contractual term from date-of-grant, vesting ratably over twelve quarters commencing with the grant date quarter, with a weighted average exercise price of $2.18 per share of common stock of PAVmed Inc.        
Weighted average fair value of stock options             $ 0.92   $ 0.93    
Expected dividend rate             0.00%        
2014 Equity Plan [Member] | Non-employees [Member]                      
Weighted average fair value of stock options                 $ 1.90    
Contractual term                 8 years 8 months 12 days    
Expected stock price volatility                 60.00%    
Risk free interest rate                 2.30%    
Expected dividend rate                 0.00%    
2014 Equity Plan [Member] | Restricted Stock [Member]                      
Number of restricted stock award granted 950 700                  
Number of common stock reserved         2,000   2,000        
Stock-based compensation expense $ 1,938 $ 742                  
2014 Equity Plan [Member] | Restricted Stock [Member] | General and Administrative Expenses [Member]                      
Stock-based compensation expense         $ 144 $ 62 $ 6   $ 82    
2014 Equity Plan [Member] | Restricted Stock [Member] | Research and Development Expenses [Member]                      
Stock-based compensation expense         $ 25   $ 25        
2014 Equity Plan [Member] | Restricted Stock [Member] | Employees [Member]                      
Number of restricted stock award granted   700   950              
Vesting portion of stock   2014 Equity Plan, with such restricted stock awards vesting ratably on an annual basis over a three year period with an initial annual vesting date of March 15, 2020.   2014 Equity Plan, with such restricted stock awards vesting ratably on an annual basis over a three year period with an initial annual vesting date of May 1, 2021.              
Restricted stock awards vested   234                  
2014 Equity Plan [Member] | Subsequent Event [Member] | Restricted Stock [Member]                      
Number of common stock reserved                   10,000 8,000
2014 Equity Plan [Member] | Subsequent Event [Member] | Common Stock [Member]                      
Stock options granted     100                
Stock option granted, contractual term     10 years                
Stock option granted, weighted average exercise price     $ 2.04                
Vesting portion of stock     Vesting ratably over twelve quarters commencing with the grant date quarter, with a weighted average exercise price of $2.04 per share of common stock of PAVmed Inc.                
2018 Long-Term Incentive Equity Plan [Member]                      
Number of common stock issued               3      
Weighted average fair value of stock options             $ 0.30   $ 0.39    
Contractual term of stock options               10 years      
2018 Long-Term Incentive Equity Plan [Member] | Non-employees [Member]                      
Weighted average fair value of stock options           $ 0.61     $ 0.61    
Contractual term           9 years 1 month 6 days     9 years 1 month 6 days    
Expected stock price volatility           62.00%     62.00%    
Risk free interest rate           2.20%     2.20%    
Expected dividend rate           0.00%     0.00%    
2018 Stock Plan [Member]                      
Proceeds from issuance of common stock             $ 5